1. First reports of hypersensitivity reactions induced by thalidomide …

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. … and ophthalmic chloramphenicol

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Aspirin is contraindicated in extradural blockade

   Newsletter Article 31 January 2013 Pages: 1 - 1

4. Warfarin-induced skin necrosis occurs mainly in patients with DVT or pulmonary embolism

   Newsletter Article 31 January 2013 Pages: 2 - 2

5. Allopurinol

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Amoxicillin +; clavulanic acid

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Antacids abuse

   Newsletter Article 31 January 2013 Pages: 3 - 3

8. Antidepressants

   Newsletter Article 31 January 2013 Pages: 3 - 3

9. Antineoplastics

   Newsletter Article 31 January 2013 Pages: 3 - 3

10. Antipsychotics

    Newsletter Article 31 January 2013 Pages: 3 - 3

11. Aprindine

    Newsletter Article 31 January 2013 Pages: 3 - 3

12. Azathioprine

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Baclofen

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Bleomycin/cisplatin/methotrexate

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Captopril

    Newsletter Article 31 January 2013 Pages: 4 - 4

16. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 4 - 4

17. Chloramphenicol see front page

    Newsletter Article 31 January 2013 Pages: 4 - 4

18. Ciprofloxacin

    Newsletter Article 31 January 2013 Pages: 4 - 4

19. Cisplatin

    Newsletter Article 31 January 2013 Pages: 4 - 4

20. Cisplatin see Bleomycin/cisplatin/methotrexate

    Newsletter Article 31 January 2013 Pages: 4 - 4

21. Clavulanic acid see Amoxicillin +; clavulanic acid

    Newsletter Article 31 January 2013 Pages: 4 - 4

22. Clofazimine

    Newsletter Article 31 January 2013 Pages: 4 - 5

23. Clozapine interaction

    Newsletter Article 31 January 2013 Pages: 5 - 5

24. Cytarabine

    Newsletter Article 31 January 2013 Pages: 5 - 5

25. Desipramine see Fluoxetine interaction

    Newsletter Article 31 January 2013 Pages: 5 - 5

26. Dextran

    Newsletter Article 31 January 2013 Pages: 5 - 5

27. Diphenhydramine

    Newsletter Article 31 January 2013 Pages: 5 - 5

28. Diuretics

    Newsletter Article 31 January 2013 Pages: 5 - 5

29. Edatrexate

    Newsletter Article 31 January 2013 Pages: 5 - 5

30. Enalapril

    Newsletter Article 31 January 2013 Pages: 5 - 5

31. Etoposide

    Newsletter Article 31 January 2013 Pages: 5 - 6

32. Flecainide

    Newsletter Article 31 January 2013 Pages: 6 - 6

33. Fluoxetine

    Newsletter Article 31 January 2013 Pages: 6 - 6

34. Fluoxetine interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

35. Granulocyte-macrophage colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Griseofulvin

    Newsletter Article 31 January 2013 Pages: 7 - 7

37. Hetastarch

    Newsletter Article 31 January 2013 Pages: 7 - 7

38. Lidocaine

    Newsletter Article 31 January 2013 Pages: 7 - 7

39. Lithium

    Newsletter Article 31 January 2013 Pages: 7 - 7

40. Low molecular weight heparin

    Newsletter Article 31 January 2013 Pages: 7 - 7

41. Maprotiline/propranolol

    Newsletter Article 31 January 2013 Pages: 7 - 8

42. Medroxyprogesterone

    Newsletter Article 31 January 2013 Pages: 8 - 8

43. Megestrol

    Newsletter Article 31 January 2013 Pages: 8 - 8

44. Mepacrine

    Newsletter Article 31 January 2013 Pages: 8 - 8

45. Methazolamide

    Newsletter Article 31 January 2013 Pages: 8 - 8

46. Methotrexate see Bleomycin/cisplatin/methotrexate

    Newsletter Article 31 January 2013 Pages: 8 - 8

47. Metronidazole see Tinidazole

    Newsletter Article 31 January 2013 Pages: 8 - 8

48. Mianserin overdose

    Newsletter Article 31 January 2013 Pages: 8 - 9

49. Midazolam

    Newsletter Article 31 January 2013 Pages: 9 - 9

50. Nortriptyline see Fluoxetine interaction

    Newsletter Article 31 January 2013 Pages: 9 - 9